| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
AR2 A COST-EFFECTIVENESS ANALYSIS OF BIOLOGICAL TREATMENTS FOR RHEUMATOID ARTHRITI ARTHRITIS
|
Chiou, CF
|
|
2004
|
7 |
Supplement 1 |
p. 223-
1 p.
|
artikel
|
| 2 |
Assessment of Health-Related Quality of Life in Children: A Review of Conceptual, Methodological, and Regulatory Issues
|
Matza, Louis S.
|
|
2004
|
7 |
Supplement 1 |
p. 79-92
14 p.
|
artikel
|
| 3 |
CV5 THE COSTS AND EFFECTS OF CLOPIDOGREL IN COMPARISON TO ASA OR PLACEBO FOR SEVERAL PATIENT POPULATIONS IN DENMARK
|
Heeg, BMS
|
|
2004
|
7 |
Supplement 1 |
p. 642-
1 p.
|
artikel
|
| 4 |
Estimating a Preference-Based Single Index for the Impact of Weight on Quality of Life-Lite (IWQOL-Lite) Instrument from the SF-6D
|
Brazier, John E.
|
|
2004
|
7 |
Supplement 1 |
p. 490-498
9 p.
|
artikel
|
| 5 |
Estimating Survival for Cost-Effectiveness Analyses: A Case Study in Atherothrombosis
|
Caro, J. Jaime
|
|
2004
|
7 |
Supplement 1 |
p. 627-635
9 p.
|
artikel
|
| 6 |
HP4 DRUG COSTS DEVELOPMENT AFTER PATENT EXPIRY IN THE THE NETHERLANDS
|
Boersma, C
|
|
2004
|
7 |
Supplement 1 |
p. 652-
1 p.
|
artikel
|
| 7 |
HPI THE RELATIONSHIP BETWEEN HEALTH INSURANCE TYPE AND COSTS OF PRESCRIBED DRUGS
|
Ngorsuraches, S
|
|
2004
|
7 |
Supplement 1 |
p. 651-
1 p.
|
artikel
|
| 8 |
HP6 MODELLING USE OF HOSPITAL SERVICES AS A FUNCTION OF NEEDS AND SUPPLY IN ITALY
|
Petrelli, A
|
|
2004
|
7 |
Supplement 1 |
p. 656-
1 p.
|
artikel
|
| 9 |
Impact of Anemia on Hospitalization Time, Charges, and Mortality in Patients with Heart Failure
|
Nordyke, Robert J.
|
|
2004
|
7 |
Supplement 1 |
p. 464-471
8 p.
|
artikel
|
| 10 |
MH4 ASSESSMENT OF HEALTH STATE UTILITIES FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER IN CHILDREN USING PARENT-BASED STANDARD GAMBL SCORES
|
Secnik, K
|
|
2004
|
7 |
Supplement 1 |
p. 236-
1 p.
|
artikel
|
| 11 |
ND3 MEDICAL SERVICES UTILIZATION FOR PATIENTS WITH PARKINSON'S DISEASE IN A STATE MEDICAID PROGRAM
|
Kamat, S
|
|
2004
|
7 |
Supplement 1 |
p. 237-
1 p.
|
artikel
|
| 12 |
Outcomes and Costs of Risperidone versus Olanzapine in Patients with Chronic Schizophrenia or Schizoaffective Disorders: A Markov Model
|
Vera-Llonch, Montserrat
|
|
2004
|
7 |
Supplement 1 |
p. 569-584
16 p.
|
artikel
|
| 13 |
Out-of-Pocket Health-Care Expenditures among Older Americans with Cancer
|
Langa, Kenneth M.
|
|
2004
|
7 |
Supplement 1 |
p. 186-194
9 p.
|
artikel
|
| 14 |
PAA19 CONSUMER SATISFACTION WITH ASTHMA TREATMENT—WHAT MATTERS?
|
Prütz, C
|
|
2004
|
7 |
Supplement 1 |
p. 315-
1 p.
|
artikel
|
| 15 |
PAA8 COST ESTIMATION IN CLINICAL PIGGY-BACK STUDIES WITH DISCONTINUATIONS—COMPARISON OF DIFFERENT APPROACHES
|
Svensson, K
|
|
2004
|
7 |
Supplement 1 |
p. 660-
1 p.
|
artikel
|
| 16 |
PAA16 PREDICTORS OF SELF-REPORTED ADHERENCE IN PATIENTS WITH ASTHMA
|
De Smet, BD
|
|
2004
|
7 |
Supplement 1 |
p. 314-
1 p.
|
artikel
|
| 17 |
PAA2 THE PREVALENCE OF INAPPROPRIATE USE OF SHORTACTING ASTHMA MEDICATION
|
Hong, SH
|
|
2004
|
7 |
Supplement 1 |
p. 309-
1 p.
|
artikel
|
| 18 |
PAR 16 CO-PAYMENTS IN RHEUMATOID ARTHRITIS OBSERVED IN A GERMAN COHORT
|
Mittendorf, T
|
|
2004
|
7 |
Supplement 1 |
p. 665-
1 p.
|
artikel
|
| 19 |
PAR 13 COST-EFFECTIVENESS OFVALDECOXIB COMPARED TO DICLOFENAC IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) IN THE UK (UK) AND GERMANY
|
Alten, RH
|
|
2004
|
7 |
Supplement 1 |
p. 664-
1 p.
|
artikel
|
| 20 |
PAR10 IMPROVING THE SENSITIVITY OF PHYSICAL FUNCTION MEASURES IN RHEUMATOID ARTHRITIS: USE OF ITEM RESPONSE THEORY IN PATIENTS TREATED WITH ABATACEPT (CTLA4IG)
|
Martin, M
|
|
2004
|
7 |
Supplement 1 |
p. 243-
1 p.
|
artikel
|
| 21 |
PCN9 COST EFFECTIVENESS OF ADDING BISPHOSPHONATES TO THE NON-SURGICAL ANDROGEN DEPRIVATION THERAPY FOR FRACTURE REDUCTION IN PATIENTS WITH NONMETASTATIC PROSTATE CANCER
|
Phatak, HM
|
|
2004
|
7 |
Supplement 1 |
p. 248-
1 p.
|
artikel
|
| 22 |
PCN2 COST-EFFECTIVENESS OF IMATINIB (GLEEVEC)AS FIRST-LINE TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
|
El Ouagari, K
|
|
2004
|
7 |
Supplement 1 |
p. 669-
1 p.
|
artikel
|
| 23 |
PCN37 DIFFERENCES IN TREATMENT PRACTICE, RESPONSE RATES AND COST OF EPOETIN ALFA AND DARBEPOETIN ALFA TREATMENT FOR ANEMIC CANCER PATIENTS: A RETROSPECTIVE ANALYSIS FROM SWEDEN
|
Persson, U
|
|
2004
|
7 |
Supplement 1 |
p. 681-
1 p.
|
artikel
|
| 24 |
PCN6 FACTORS INFLUENCING PHYSICIAN RECOMMENDATION FOR IMATINIB MESYLATE IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA (CML) PATIENTS
|
Iyer, SS
|
|
2004
|
7 |
Supplement 1 |
p. 247-
1 p.
|
artikel
|
| 25 |
PCNI9 NEW TARGETED THERAPY FOR PATIENTS WITH PREVIOUSLY-TREATED ADVANCED NON-SMALL CELL LUNG CANCER—GEFITINIB (“IRESSA”)
|
de Peuter, R
|
|
2004
|
7 |
Supplement 1 |
p. 675-
1 p.
|
artikel
|
| 26 |
PCN34 UTILITY ASSOCIATED WITH SEVERITY OF CANCER-RELATED ANAEMIA (CRA): A SOCIETAL VALUATION
|
Ossa, DF
|
|
2004
|
7 |
Supplement 1 |
p. 680-
1 p.
|
artikel
|
| 27 |
PCN23 XEROSTOMIA SYMPTOMS: A NEWLY DEVELOPED PATIENT REPORTED OUTCOMES QUESTIONNAIRE
|
Colwell, HH
|
|
2004
|
7 |
Supplement 1 |
p. 252-253
2 p.
|
artikel
|
| 28 |
PCO5 ECONOMIC BURDEN OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN A STATE HEALTH INSURANCE PROGRAM
|
Joshi, AV
|
|
2004
|
7 |
Supplement 1 |
p. 257-
1 p.
|
artikel
|
| 29 |
PCV74 A METHOD FOR IDENTIFYING PATIENTS WITH CHRONIC ANGINA FROM ADMINISTRATIVE CLAIMS DATA
|
Watson, JB
|
|
2004
|
7 |
Supplement 1 |
p. 707-
1 p.
|
artikel
|
| 30 |
PCV57 CHRONIC VENOUS DISEASE: COMPLIANCE WITH TREATMENT
|
Guex, JJ
|
|
2004
|
7 |
Supplement 1 |
p. 702-
1 p.
|
artikel
|
| 31 |
PCV22 COST AND COMORBIDITIES ASSOCIATED WITH ATRIAL FIBRILLATION IN DIFFERENT AGE GROUPS
|
Wu, EQ
|
|
2004
|
7 |
Supplement 1 |
p. 324-
1 p.
|
artikel
|
| 32 |
PCV29 COST-EFFECTIVENESS OF REDUCTION IN CARDIOVASCULAR OUTCOMES WITH ATORVASTATIN IN PATIENTS WITH NORMAL TO MILDLY ELEVATED CHOLESTEROL LEVELS.TREATED FOR HYPERTENSION: THE ASCOT-LLA STUDY
|
Lindgren, P
|
|
2004
|
7 |
Supplement 1 |
p. 694-
1 p.
|
artikel
|
| 33 |
PCV49 DOES THE RATE OF MEDICARE MANAGED-CARE PENETRATION AFFECT AVAILABILITY OF RESOURCES FOR HEART FAILURE TREATMENT?
|
Masselink, LE
|
|
2004
|
7 |
Supplement 1 |
p. 333-
1 p.
|
artikel
|
| 34 |
PCVI6 EVOLUTION OF PRESCRIPTIONS AND DRUG COSTS IN HYPERTENSION—RESULTS FROM A DATABASE FOLLOW-UP STUDY
|
Berger, W
|
|
2004
|
7 |
Supplement 1 |
p. 690-
1 p.
|
artikel
|
| 35 |
PCV26 THE COST-EFFECTIVENESS OF EXTENDED ANTITHROMBOTIC PROPHYLAXIS FOLLOWING TOTAL HIP ARTHROPLASTY
|
Skedgel, CD
|
|
2004
|
7 |
Supplement 1 |
p. 693-
1 p.
|
artikel
|
| 36 |
PCV43 THE IMPACT OF LOW MOLECULAR WEIGHT HEPARIN (LMWH) ENOXAPARIN USAGE ON OUTCOMES OF TREATMENT MANAGEMENT OF PATIENTS WITH ACUTE CORONARY SYNDROMES (ACS) IN RUSSIA
|
Vorobiov, PA
|
|
2004
|
7 |
Supplement 1 |
p. 698-
1 p.
|
artikel
|
| 37 |
PCV3 TIME TO LDL-CHOLESTEROL GOAL ATTAINMENT IN SPAIN
|
Olivares, O
|
|
2004
|
7 |
Supplement 1 |
p. 685-
1 p.
|
artikel
|
| 38 |
PCV25 TOBACCO COST-EFFECTIVENESS ANALYSES AND THE PAYER: IS THE SHORT TERM LONG OVERDUE?
|
Reed, KE
|
|
2004
|
7 |
Supplement 1 |
p. 325-
1 p.
|
artikel
|
| 39 |
PCV60 TREATMENT OF NEWLY-DIAGNOSED HYPERTENSIVE PATIENTS IN ITALYA RETROSPECTIVE COHORT STUDY IN PRIMARY CARE
|
Bustacchini, S
|
|
2004
|
7 |
Supplement 1 |
p. 703-
1 p.
|
artikel
|
| 40 |
PCV35 VALIDATION OF THE EQ-5D QUESTIONNAIRE IN PATIENTS WITH A HISTORY OF ACUTE CORONARY SYNDROME
|
Ellis, JJ
|
|
2004
|
7 |
Supplement 1 |
p. 328-329
2 p.
|
artikel
|
| 41 |
PCV8 WARFARIN ANTICOAGULATION AND OUTCOMES IN ATRIAL FIBRILLATION PATIENTS:A SYSTEMATIC REVIEW AND META-ANALYSIS
|
Reynolds, MW
|
|
2004
|
7 |
Supplement 1 |
p. 320-
1 p.
|
artikel
|
| 42 |
PDB20 COST-EFFECTIVENESS OF DULOXETINE VERSUS ROUTINE TREATMENT FOR PAINFUL DIABETIC NEUROPATHY IN A RANDOMIZED TRIAL FROM A SOCIETAL PROSPECTIVE
|
Wu, EQ
|
|
2004
|
7 |
Supplement 1 |
p. 342-343
2 p.
|
artikel
|
| 43 |
PDB19 COST OF HOSPITAL ADMISSIONS FOR CARDIOVASCULAR DISEASE OVER FIVE YEARS IN PATIENTS WITH DIABETES MELLITUS
|
O'Brien, JA
|
|
2004
|
7 |
Supplement 1 |
p. 740-
1 p.
|
artikel
|
| 44 |
PDB16 EFFECT OF PATIENT EDUCATION IN TYPE-2 DIABETES OVER 10 YEARS BASED ON A PROSPECTIVE DIABETES MODEL IN THE PROVINCE OF STYRIA, AUSTRIA
|
Habacher, W
|
|
2004
|
7 |
Supplement 1 |
p. 739-740
2 p.
|
artikel
|
| 45 |
PDB12 ESTIMATING THE REDUCTION IN LONG TERM COMPLICATION AND COSTS OF COMPLICATIONS IN TYPE 1 DIABETES BY REDUCED A1C LEVELS DUE TO MORE FREQUENT BLOOD GLUCOSE MONITORING
|
Nicklasson, L
|
|
2004
|
7 |
Supplement 1 |
p. 340-
1 p.
|
artikel
|
| 46 |
PDB2 EVALUATION OF IMPROVED UTILITY ESTIMATES IN COST EFFECTIVENESS ANALYSIS OF MULTIPLE COMPLICATIONS IN TYPE-2 DIABETES
|
McEwan, P
|
|
2004
|
7 |
Supplement 1 |
p. 735-
1 p.
|
artikel
|
| 47 |
PDB3 EVALUATION OF PHARMACIST INTERVENTIONS IN DIABETIC PATIENTS FROM RURAL COMMUNITY HEALTH CENTERS
|
Pinto, S
|
|
2004
|
7 |
Supplement 1 |
p. 337-
1 p.
|
artikel
|
| 48 |
PDB6 GENDER DISPARITY IN THE MANAGEMENT OF DYSLIPIDEMIA AMONG TYPE 2 DIABETES PATIENTS IN A MANAGED-CARE SETTING
|
Mallya, UG
|
|
2004
|
7 |
Supplement 1 |
p. 338-
1 p.
|
artikel
|
| 49 |
PDB32 LONG-TERM DIABETES COMPLICATIONS: INFLUENCE OF DELAY IN STARTING INTENSIFIED THERAPY AND OF PATIENT RATES TREATED TO TARGET A1C.ANALYSES WITH THE DIABETES MELLITUS MODEL (DMM)
|
Bergemann, R
|
|
2004
|
7 |
Supplement 1 |
p. 745-
1 p.
|
artikel
|
| 50 |
PDB26 PREFERENCE, EFFICACY, SAFETY AND ACTUAL USE OF BLOOD GLUCOSE (BG) MONITORING WITH INDUO® VS SYRINGE AND SEPARATE METER IN SUBJECTS WITH TYPE 1 DIABETES
|
Bode, B
|
|
2004
|
7 |
Supplement 1 |
p. 344-345
2 p.
|
artikel
|
| 51 |
PES15 IMPACT OF ATOPIC DERMATITIS ON PARENTΨS QUALITY OF LIFE AND USE OF DIRECT RESOURCES IN PATIENTS BETWEEN 2 AND 12 YEARS OLD. DAES STUDY
|
Espinosa, C
|
|
2004
|
7 |
Supplement 1 |
p. 750-
1 p.
|
artikel
|
| 52 |
PES2 MEDICATION ADHERENCE RATES AND DISEASE SEVERITY CHANGES IN PSORIASIS
|
Balkrishnan, R
|
|
2004
|
7 |
Supplement 1 |
p. 258-
1 p.
|
artikel
|
| 53 |
PES16 VALIDATION OF A NEW SELF-ASSESSMENT QUESTIONNAIRE AND THE SKINDEX-29 QUALITY OF LIFE (QOL) INSTRUMENT FOR CHRONIC HAND DERMATITIS (CHHD): A PILOT STUDY
|
Fowler, J
|
|
2004
|
7 |
Supplement 1 |
p. 262-263
2 p.
|
artikel
|
| 54 |
PE2 THE EFFECTS OF ANTIDEPRESSANT DRUGS ON THE RISK OF COLORECTAL CANCER:A POPULATION-BASED CASE-CONTROL STUDY
|
Xu, W
|
|
2004
|
7 |
Supplement 1 |
p. 232-
1 p.
|
artikel
|
| 55 |
PGI5 COSTS BENEFITS WITH ESOMEPRAZOLE 20MG “ONDEMAND” TREATMENT IN GASTROESOPHAGEAL REFLUX DISEASE (GERD) PATIENTS IN BELGIUM
|
Louis, E
|
|
2004
|
7 |
Supplement 1 |
p. 754-755
2 p.
|
artikel
|
| 56 |
PGI7 FECAL LACTOFERRIN ASSAY FOR THE INITIAL DIAGNOSTIC APPROACH TO SYMPTOMATIC PATIENTS WITH ILEAL POUCH-ANAL ANASTOMOSIS:A COST-EFFECTIVENESS ANALYSIS
|
Ellis, JJ
|
|
2004
|
7 |
Supplement 1 |
p. 348-
1 p.
|
artikel
|
| 57 |
PGI8 PHARMACOECONOMIC ASPECTS OF CROHN'S DISEASE IN SLOVAKIA
|
Bielik, J
|
|
2004
|
7 |
Supplement 1 |
p. 755-756
2 p.
|
artikel
|
| 58 |
PHP14 ECONOMIC ASPECTS OF INDIVIDUAL TREATMENT IN POLAND—OUT-PATIENT VIEWPOINT
|
Czech, M
|
|
2004
|
7 |
Supplement 1 |
p. 713-
1 p.
|
artikel
|
| 59 |
PHP34 EXPLICIT INDICATORS TO MEASURE PREVENTABLE DRUG-RELATED MORBIDITY IN AN ELDERLY POPULATION
|
Faris, RJ
|
|
2004
|
7 |
Supplement 1 |
p. 377-
1 p.
|
artikel
|
| 60 |
PHP3 HANDGUN INJURIES TO CHILDREN AND TEENS RESULTING IN HOSPITALIZATION: CIRCUMSTANCES, RESOURCE USE AND COSTS
|
O'Brien, J
|
|
2004
|
7 |
Supplement 1 |
p. 367-368
2 p.
|
artikel
|
| 61 |
PHP31 POTENTIALLY INAPPROPRIATE PRESCRIBING FOR OLDER VETERANS:WHO'S AT RISK?
|
Pugh, MJV
|
|
2004
|
7 |
Supplement 1 |
p. 376-
1 p.
|
artikel
|
| 62 |
PHP17 RECENT TRENDS IN INPATIENT DRUG COSTS: 2000-2002
|
DA, Foster
|
|
2004
|
7 |
Supplement 1 |
p. 372-
1 p.
|
artikel
|
| 63 |
PHP31 SENSIBLE FLEXIBILITY OR UNNECESSARY DUPLICATION] THE USE OF DECISION MODELLING IN NICE APPRAISALS
|
Hutton, J
|
|
2004
|
7 |
Supplement 1 |
p. 718-
1 p.
|
artikel
|
| 64 |
PHP28 THE ORGANIZED REGISTER OF CANADIAN HEALTH INFORMATION DATABASES (ORCHID) PROJECT: A RESEARCHER INTERFACE
|
Gibson, D
|
|
2004
|
7 |
Supplement 1 |
p. 717-
1 p.
|
artikel
|
| 65 |
PIN12 COST-EFFECTIVENESS OF INTRAVENOUS IMMUNOGLOBULIN MANUFACTURED FROM CHROMOTOGRAPHY-CAPRYLATE VS. SOLVENT-DETERGENT METHODS IN PERSONS WITH PRIMARY IMMUNODEFICIENCY DISEASE
|
Mahadevia, PJ
|
|
2004
|
7 |
Supplement 1 |
p. 354-
1 p.
|
artikel
|
| 66 |
PIN8 ECONOMIC EVALUATION OF HIV TREATMENTS: THE I.CO.N.A. COHORT STUDY
|
Merito, M
|
|
2004
|
7 |
Supplement 1 |
p. 760-
1 p.
|
artikel
|
| 67 |
PIN24 IMPROVEMENT IN PATIENT-REPORTED DEPRESSION IN HIV+ PATIENTS EXPERIENCING GRADE 2 SIDE EFFECTS AFTER SUBSTITUTION OF THEIR PROTEASE INHIBITOR (PI)/NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR (NNRTI) WITH LOPINAVIR/RITONAVIR (LPV/R)
|
Luo, MP
|
|
2004
|
7 |
Supplement 1 |
p. 765-766
2 p.
|
artikel
|
| 68 |
PIN26 MENINGOCOCCAL VACCINE IN PORTUGAL–A COST-EFFECTIVENESS ANALYSIS
|
Gouveia, M
|
|
2004
|
7 |
Supplement 1 |
p. 358-
1 p.
|
artikel
|
| 69 |
PIN22 MODELLING THE COST-EFFECTIVENESS OF ACTIVATED PROTEIN C (XIGRIS®) TREATMENT OF SEPTIC PATIENTS ININTENSIVE CARE UNITS IN HUNGARY
|
Hoffer, G
|
|
2004
|
7 |
Supplement 1 |
p. 764-765
2 p.
|
artikel
|
| 70 |
PIN9 VARIABILITY IN THE USE OF HIV PHENOTYPIC TESTING BY SPECIALTY OF PRACTITIONER
|
Hess, GP
|
|
2004
|
7 |
Supplement 1 |
p. 353-
1 p.
|
artikel
|
| 71 |
PMC9 HEALTH PROGRAM IMPACT EVALUATION USING OBSERVED AND EXPECTED TIME SERIES OF PHARMACEUTICAL CONSUMPTIONS
|
Menna, A
|
|
2004
|
7 |
Supplement 1 |
p. 771-772
2 p.
|
artikel
|
| 72 |
PMD13 ADHERENCE INDEX: A NEW AND IMPROVED APPROACH TO MEASURE MEDICATION COMPLIANCE
|
Chaikledkaew, U
|
|
2004
|
7 |
Supplement 1 |
p. 304-
1 p.
|
artikel
|
| 73 |
PMH9 ANALYSIS OF ANTIDEPRESSANT MEDICATION UTILIZATION AND ADHERENCE OF MANAGED CARE PATIENTS ENROLLED IN A MEDICATION ADHERENCE PROGRAM
|
Cockerham, TR
|
|
2004
|
7 |
Supplement 1 |
p. 266-
1 p.
|
artikel
|
| 74 |
PMH60 ANALYSIS OF LONGITUDINAL CLAIMS DATA TO EXAMINE FIRST AND SECOND-LINE USE OF PEMOLINE (CYLERT®)
|
Morrato, E
|
|
2004
|
7 |
Supplement 1 |
p. 282-
1 p.
|
artikel
|
| 75 |
PMH74 COMPARING PSYCHOMETRIC PROPERTIES OF SELF-VERSUS INTERVIEWER-RATED INSTRUMENTS USED IN CLINICAL TRIALS FOR PATIENTS WITH ANXIETY DISORDERS
|
Lau, DT
|
|
2004
|
7 |
Supplement 1 |
p. 286-
1 p.
|
artikel
|
| 76 |
PMH42 CORRELATIONS BETWEEN PSYCHOPATHOLOGY AND HEALTH RELATED QUALITY OF LIFE (HRQOL) MEASURES IN SCHIZOPHRENIA. RESULTS FROM THE SQUARE STUDY
|
Karokis, A
|
|
2004
|
7 |
Supplement 1 |
p. 276-
1 p.
|
artikel
|
| 77 |
PMH17 COST-UTILITY ANALYSIS OF MEDICAL CO-PRESCRIPTION OF HEROIN COMPARED WITH METHADONE MAINTENANCE TREATMENT FOR CHRONIC, TREATMENT RESISTANT HEROIN ADDICTS
|
Dijkgraaf, MGW
|
|
2004
|
7 |
Supplement 1 |
p. 781-
1 p.
|
artikel
|
| 78 |
PMH3 FOLLOW-UP OF SCHIZOPHRENIA PATIENTS DISCHARGED ON RISPERIDONE OR OLANZAPINE: A TIME-TO-EVENT ANALYSIS
|
Adriaenssen, I
|
|
2004
|
7 |
Supplement 1 |
p. 776-777
2 p.
|
artikel
|
| 79 |
PMH45 MAPPING UTILITY SCORES FROM THE EQ-5D AND SF-6D ONTO THE SCHIZOPHRENIA QUALITY OF LIFE SCALE
|
Clayson, DJ
|
|
2004
|
7 |
Supplement 1 |
p. 277-
1 p.
|
artikel
|
| 80 |
PMH77 ORDERING EFFECTS IN CROSSOVER STUDIES OF PHOTOTHERAPY: IMPLICATIONS FOR PSYCHOLOGICAL INTERVENTIONS
|
Chapell, R
|
|
2004
|
7 |
Supplement 1 |
p. 287-
1 p.
|
artikel
|
| 81 |
PMH26 OUT-OF-POCKET DRUG EXPENDITURES AND PATTERNS OF DEPRESSION IN THE ELDERLY: A 5-YEAR POPULATIONBASED STUDY
|
Dalal, M
|
|
2004
|
7 |
Supplement 1 |
p. 271-
1 p.
|
artikel
|
| 82 |
PMH19 THE PERCEIVED BENEFITS OF DOSING SCHEDULES FOR CHILDREN WITH ADHD
|
Price, M
|
|
2004
|
7 |
Supplement 1 |
p. 782-
1 p.
|
artikel
|
| 83 |
PMW1 ECONOMIC EVALUATION OF THE ADMINISTRATION OF FOLLITROPIN-Â WITH A PEN DEVICE COMPARED WITH ADMINISTRATION OF MENOTROPIN BY CONVENTIONAL SYRINGE
|
Bruijnesteijn, K
|
|
2004
|
7 |
Supplement 1 |
p. 785-
1 p.
|
artikel
|
| 84 |
PNL24 COMPARING CLASSIFICATION AND REGRESSION TREE ANALYSIS WITH MULTIPLE REGRESSION FOR TRANSLATING A CLINICAL PARKINSON'S DISEASE SCALE INTO UTILITIES
|
Siebert, U
|
|
2004
|
7 |
Supplement 1 |
p. 795-
1 p.
|
artikel
|
| 85 |
PNL12 COST UTILITY ANALYSIS OF INTERFERON BETA-1A (AVONEX®) IN PRE-CLINICALLY DEFINITE MULTIPLE SCLEROSIS (CDMS)
|
Iskedjian, M
|
|
2004
|
7 |
Supplement 1 |
p. 291-
1 p.
|
artikel
|
| 86 |
PNL22 EFFECT OF DISEASE-SPECIFIC COMPLICATIONS ON THE PREDICTION OF UTILITIES IN PARKINSON'S DISEASE
|
Siebert, U
|
|
2004
|
7 |
Supplement 1 |
p. 794-
1 p.
|
artikel
|
| 87 |
PNL9 INDIRECT COSTS ASSOCIATED TO INSOMNIA IN OCCUPATIONAL HEALTH: THE SISYPHE STUDY
|
Godet-Cayré, V
|
|
2004
|
7 |
Supplement 1 |
p. 789-
1 p.
|
artikel
|
| 88 |
POB3 EVALUATION OF THE COST-UTILITY OF ORLISTAT (XENICAL) IN THE UNITED KINGDOM
|
McEwan, P
|
|
2004
|
7 |
Supplement 1 |
p. 721-
1 p.
|
artikel
|
| 89 |
POS2 DIFFERENCES BETWEEN DOCTOR AND PATIENT RECALL OF EVENTS IN AND INVESTIGATIONS FOR OSTEOPOROSIS IN FIVE COUNTRIES
|
Piercy, J
|
|
2004
|
7 |
Supplement 1 |
p. 296-
1 p.
|
artikel
|
| 90 |
PPN5 AN OPIATE RENEWAL CLINIC:A COST EFFECTIVE APPROACH TO REDUCING UNSCHEDULED PATIENT VISITS
|
Sampson, JM
|
|
2004
|
7 |
Supplement 1 |
p. 299-
1 p.
|
artikel
|
| 91 |
PPN8 PATTERNS AND TRENDS IN OPIOID USE AMONG INDIVIDUALS WITH BACK PAIN IN THE UNITED STATES
|
Luo, X
|
|
2004
|
7 |
Supplement 1 |
p. 300-
1 p.
|
artikel
|
| 92 |
PPN2 RESOURCE UTILISATION OF PATIENTS WITH CHRONIC PAIN CONDITIONS BEFORE AND DURING TREATMENT WITH LONG-ACTING OPIOIDS IN GERMANY
|
Burkowitz, J
|
|
2004
|
7 |
Supplement 1 |
p. 725-
1 p.
|
artikel
|
| 93 |
PRS4 COST OF TREATMENT AND REIMBURSEMENT OF HOSPITALIZED COMMUNITY-ACQUIRED PNEUMONIA WITH I.V. MOXIFLOXACIN COMPARED TO STANDARD ANTIBIOTIC TREAMENT IN GERMANY
|
De Zeeuw, J
|
|
2004
|
7 |
Supplement 1 |
p. 729-730
2 p.
|
artikel
|
| 94 |
PRS7 THE CHRONIC OBSTRUCTIVE PULMONARY DISEASE HAS A NEGATIVE IMPACT ON THE QUALITY OF LIFE OF THE PATIENT: THE RESULTS OF THE EPIDEPOC STUDY
|
García, M
|
|
2004
|
7 |
Supplement 1 |
p. 730-731
2 p.
|
artikel
|
| 95 |
PSD2 ANTIDEPRESSANT-INDUCED SEXUAL DYSFUNCTION (ADSD) IN EUROPE:A PRELIMINARY INVESTIGATION
|
Williams, VSL
|
|
2004
|
7 |
Supplement 1 |
p. 361-362
2 p.
|
artikel
|
| 96 |
PUK20 IMPLICATIONS OF OVERACTIVE BLADDER ICD-9 CODE CHANGES AND USE OF CODES IN A MANAGED CARE POPULATION
|
Nitz, NM
|
|
2004
|
7 |
Supplement 1 |
p. 804-
1 p.
|
artikel
|
| 97 |
PUK23 LANTHANUM CARBONATE FOR THE TREATMENT OF HYPERPHOSPHATAEMIA: DEVELOPMENT OF A COSTEFFECTIVENESS MODEL
|
Brennan, A
|
|
2004
|
7 |
Supplement 1 |
p. 805-
1 p.
|
artikel
|
| 98 |
PUK13 VALIDATION OF AUTOMATED DATABASE ALGORITHMS TO IDENTIFY HOSPITAL-ACQUIRED ACUTE RENAL FAILURE
|
Winterstein, AG
|
|
2004
|
7 |
Supplement 1 |
p. 366-367
2 p.
|
artikel
|
| 99 |
PUK7 WHEN SHOULD ERYTHROPOIETIN (EPO) BE REPLACED BY PACKED RED BLOOD CELL TRANSFUSION (TR) IN HEMODIALYSIS (HD) PATIENTS?
|
Kuehne, FC
|
|
2004
|
7 |
Supplement 1 |
p. 799-
1 p.
|
artikel
|
| 100 |
QL2 THE HEALTH RELATED QUALITY OF LIFE IN PARKINSON'S DISEASE IN GERMANY
|
Spottke, EA
|
|
2004
|
7 |
Supplement 1 |
p. 641-
1 p.
|
artikel
|
| 101 |
QL7 VALIDATION OF A PATIENT-ADMINISTERED QUESTIONNAIRE TO MEASURE THE SEVERITY OF LOWER URINARY TRACT SYMPTOMS IN UNCOMPLICATED URINARY TRACT INFECTION:THE UTI SYMPTOM ASSESSMENT (USA) QUESTIONNAIRE
|
Clayson, DJ
|
|
2004
|
7 |
Supplement 1 |
p. 646-
1 p.
|
artikel
|
| 102 |
Resource Utilization and Costs of Stroke Unit Care in Germany
|
Dodel, Richard C.
|
|
2004
|
7 |
Supplement 1 |
p. 144-152
9 p.
|
artikel
|
| 103 |
Return on Investment of Different Combinations of Bupropion SR Dose and Behavioral Treatment for Smoking Cessation in a Health Care Setting: An Employer's Perspective
|
Javitz, Harold S.
|
|
2004
|
7 |
Supplement 1 |
p. 535-543
9 p.
|
artikel
|
| 104 |
SC4 ECONOMIC EVALUATION OF SCREENING FOR THE A-ADDUCIN GENE VARIANT IN HYPERTENSIVE PATIENTS
|
Meckley, LM
|
|
2004
|
7 |
Supplement 1 |
p. 228-229
2 p.
|
artikel
|
| 105 |
Systematic Assessment of Decision Models in Parkinson's Disease
|
Siebert, Uwe
|
|
2004
|
7 |
Supplement 1 |
p. 610-626
17 p.
|
artikel
|
| 106 |
The Economic Impact of Payer Policies after the Rx-to-OTC Switch of Second-Generation Antihistamines * * Preliminary results of this analysis were presented at the 9th annual HMO Research Network Conference April 1-2, 2003
|
Sullivan, Patrick W.
|
|
2004
|
7 |
Supplement 1 |
p. 402-412
11 p.
|
artikel
|
| 107 |
UC1 HEALTH ECONOMIC COMPARISON OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION WITH MULTIPLE DAILY INJECTION FOR THE TREATMENT OF TYPE 1 DIABETES IN THE UK
|
Zakrzewska, K
|
|
2004
|
7 |
Supplement 1 |
p. 649-650
2 p.
|
artikel
|
| 108 |
Using Clopidogrel in Non-ST-Segment Elevation Acute Coronary Syndrome Patients: A Cost–Utility Analysis in Spain
|
Latour-Pérez, Jaime
|
|
2004
|
7 |
Supplement 1 |
p. 52-60
9 p.
|
artikel
|
Tijdschrift beschrijving